Slingshot members are tracking this event:
CRISPR and Casebia by Bayer (BAYRY) obtain rights to MaxCyte's cell engineering platform to create therapies for hemoglobin disorders and immunodeficiency
Slingshot Insights Explained
Mar 14, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Immunodeficiency, Hemoglobin, Maxcyte